Theralase “TLT” Discovers Anti-Cancer Memory Response

Theralase Technologies Inc. (CVE:TLT) (OTCBB: TLTFF) announced that in preclinical animal testing, performed at Princess Margaret Cancer Centre, University Health Network, it has discovered that its lead Photo Dynamic Compound (PDC), intended for the destruction of cancer, has demonstrated an ability to render animals immune to repeated exposures of the same cancer.In previous research conducted… Continue reading Theralase “TLT” Discovers Anti-Cancer Memory Response